134 related articles for article (PubMed ID: 8389269)
1. Treatment of septic shock with a protease inhibitor in a canine model: a prospective, randomized, controlled trial.
Tani T; Aoki H; Yoshioka T; Lin KJ; Kodama M
Crit Care Med; 1993 Jun; 21(6):925-30. PubMed ID: 8389269
[TBL] [Abstract][Full Text] [Related]
2. [Effects of ulinastatin on endotoxin shock in dogs].
Okano S; Tagawa M; Urakawa N; Ogawa R
Masui; 1992 Mar; 41(3):413-20. PubMed ID: 1560582
[TBL] [Abstract][Full Text] [Related]
3. A therapeutic effect of ulinastatin on endotoxin-induced shock in dogs--comparison with methylprednisolone.
Okano S; Tagawa M; Urakawa N; Ogawa R
J Vet Med Sci; 1994 Aug; 56(4):645-9. PubMed ID: 7999884
[TBL] [Abstract][Full Text] [Related]
4. Effect of combined nitric oxide inhalation and NG-nitro-L-arginine infusion in porcine endotoxin shock.
Weitzberg E; Rudehill A; Modin A; Lundberg JM
Crit Care Med; 1995 May; 23(5):909-18. PubMed ID: 7736750
[TBL] [Abstract][Full Text] [Related]
5. Role of nitric oxide in the hemodynamic changes of sepsis.
Lorente JA; Landín L; Renes E; De Pablo R; Jorge P; Ródena E; Liste D
Crit Care Med; 1993 May; 21(5):759-67. PubMed ID: 8482098
[TBL] [Abstract][Full Text] [Related]
6. Addition of alinidine, a specific bradycardic agent, to dobutamine in a canine model of endotoxic shock.
Preiser JC; Moulart D; Vincent JL
Crit Care Med; 1992 Aug; 20(8):1146-51. PubMed ID: 1643894
[TBL] [Abstract][Full Text] [Related]
7. Continuous arteriovenous hemofiltration does not improve survival in a canine model of septic shock.
Freeman BD; Yatsiv I; Natanson C; Solomon MA; Quezado ZM; Danner RL; Banks SM; Hoffman WD
J Am Coll Surg; 1995 Mar; 180(3):286-92. PubMed ID: 7874338
[TBL] [Abstract][Full Text] [Related]
8. The endothelin receptor antagonist, bosentan, in combination with the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock.
Wanecek M; Rudehill A; Hemsén A; Lundberg JM; Weitzberg E
Crit Care Med; 1997 May; 25(5):848-57. PubMed ID: 9187606
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic trial of lipid X in a canine model of septic shock.
Danner RL; Eichacker PQ; Doerfler ME; Hoffman WD; Reilly JM; Wilson J; MacVittie TJ; Stuetz P; Parrillo JE; Natanson C
J Infect Dis; 1993 Feb; 167(2):378-84. PubMed ID: 8421172
[TBL] [Abstract][Full Text] [Related]
10. Changes in reticuloendothelial function in dogs with endotoxin-induced shock.
Okano S; Tagawa M; Hara Y; Ejima H; Motoyoshi S; Urakawa N; Furukawa K; Onda M; Ogawa R
J Vet Med Sci; 1993 Aug; 55(4):607-11. PubMed ID: 8399741
[TBL] [Abstract][Full Text] [Related]
11. Treatment of septic shock in rats with nitric oxide synthase inhibitors and inhaled nitric oxide.
Pedoto A; Tassiopoulos AK; Oler A; McGraw DJ; Hoffmann SP; Camporesi EM; Hakim TS
Crit Care Med; 1998 Dec; 26(12):2021-8. PubMed ID: 9875915
[TBL] [Abstract][Full Text] [Related]
12. Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock.
Zhang H; Rogiers P; Preiser JC; Spapen H; Manikis P; Metz G; Vincent JL
Crit Care Med; 1995 Oct; 23(10):1711-21. PubMed ID: 7587237
[TBL] [Abstract][Full Text] [Related]
13. Glycosylated recombinant human tumor necrosis factor binding protein-1 reduces mortality, shock, and production of tumor necrosis factor in rabbit Escherichia coli sepsis.
Porat R; Paddock HN; Schwaitzberg SD; Connolly RJ; Wilkens T; Dasch JR; Gascon MP; Hutchison JS; Ythier A; Wallach D
Crit Care Med; 1995 Jun; 23(6):1080-9. PubMed ID: 7774220
[TBL] [Abstract][Full Text] [Related]
14. Effect of urinary trypsin inhibitor MR-20 in shock.
Oyama T; Miyahara T; Ishihara H; Yao M; Honda K
Prog Clin Biol Res; 1983; 111():283-91. PubMed ID: 6688131
[No Abstract] [Full Text] [Related]
15. Effect of human hemoglobin on systemic and regional hemodynamics in a porcine model of endotoxemic shock.
Aranow JS; Wang H; Zhuang J; Fink MP
Crit Care Med; 1996 May; 24(5):807-14. PubMed ID: 8706458
[TBL] [Abstract][Full Text] [Related]
16. Ulinastatin, a human trypsin inhibitor, inhibits endotoxin-induced thromboxane B2 production in human monocytes.
Aibiki M; Cook JA
Crit Care Med; 1997 Mar; 25(3):430-4. PubMed ID: 9118658
[TBL] [Abstract][Full Text] [Related]
17. Systemic and regional oxygen uptake and delivery and lactate flux in endotoxic dogs infused with dopexamine.
Cain SM; Curtis SE
Crit Care Med; 1991 Dec; 19(12):1552-60. PubMed ID: 1959377
[TBL] [Abstract][Full Text] [Related]
18. Effect of a recombinant endotoxin-neutralizing protein on endotoxin shock in rabbits.
Garcia C; Saladino R; Thompson C; Hammer B; Parsonnet J; Wainwright N; Novitsky T; Fleisher GR; Siber G
Crit Care Med; 1994 Aug; 22(8):1211-8. PubMed ID: 8045139
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of a recombinant N-terminal fragment of bactericidal/permeability-increasing protein and cefamandole in treatment of rabbit gram-negative sepsis.
Lin Y; Leach WJ; Ammons WS
Antimicrob Agents Chemother; 1996 Jan; 40(1):65-9. PubMed ID: 8787881
[TBL] [Abstract][Full Text] [Related]
20. Dobutamine improves gastrointestinal mucosal blood flow in a porcine model of endotoxic shock.
Nevière R; Chagnon JL; Vallet B; Lebleu N; Marechal X; Mathieu D; Wattel F; Dupuis B
Crit Care Med; 1997 Aug; 25(8):1371-7. PubMed ID: 9267952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
